Interim Report January – September 2018
July – September in summary · Net sales rose by about 74 percent to SEK 9,206k (5,286k). · Operating profit before depreciation and amortization (EBITDA)* totaled SEK 1,747k (loss: 1,299k). · Comprehensive income for the period improved by SEK 1,983k to a profit of SEK 342k (loss: 1,641k). · Comprehensive income per share, basic and diluted, improved by SEK 0.04 to SEK 0.01 (-0.03). · Genovis expanded its sales and marketing organization at its Lund headquarters and hired Rob Horsefield as Sales & Business Development Manager. · Genovis launched FabRICATOR®-HPLC